-
1
-
-
3042835910
-
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City
-
Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004;39:55-60.
-
(2004)
Clin. Infect. Dis.
, vol.39
, pp. 55-60
-
-
Bradford, P.A.1
Bratu, S.2
Urban, C.3
-
2
-
-
46349083189
-
Klebsiella pneumoniae Carbapenemase-2, Buenos Aires, Argentina
-
Pasteran FG, Otaegui L, Guerriero L, et al. Klebsiella pneumoniae Carbapenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 2008;14:1178-1180.
-
(2008)
Emerg. Infect. Dis.
, vol.14
, pp. 1178-1180
-
-
Pasteran, F.G.1
Otaegui, L.2
Guerriero, L.3
-
3
-
-
0342981062
-
Emergence of a carbapenem-resistant Klebsiella pneumoniae
-
MacKenzie FM, Forbes KJ, Dorai-John T, et al. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 1997;350:783.
-
(1997)
Lancet
, vol.350
, pp. 783
-
-
MacKenzie, F.M.1
Forbes, K.J.2
Dorai-John, T.3
-
4
-
-
44449165917
-
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital
-
Cai JC, Zhou HW, Zhang R, et al. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014-2018.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 2014-2018
-
-
Cai, J.C.1
Zhou, H.W.2
Zhang, R.3
-
5
-
-
33846594244
-
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China
-
Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007;51:763-765.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 763-765
-
-
Wei, Z.Q.1
Du, X.X.2
Yu, Y.S.3
-
6
-
-
34248196032
-
Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China
-
Zhang R, Zhou HW, Cai JC, et al. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 2007;59:574-576.
-
(2007)
J. Antimicrob. Chemother.
, vol.59
, pp. 574-576
-
-
Zhang, R.1
Zhou, H.W.2
Cai, J.C.3
-
7
-
-
58149188041
-
Detection and genetic characterisation of qnrB in hospital isolates of Klebsiella pneumoniae in Singapore
-
Teo JW, Ng KY, Lin RT. Detection and genetic characterisation of qnrB in hospital isolates of Klebsiella pneumoniae in Singapore. Int J Antimicrob Agents 2009;33:177-180.
-
(2009)
Int. J. Antimicrob. Agents
, vol.33
, pp. 177-180
-
-
Teo, J.W.1
Ng, K.Y.2
Lin, R.T.3
-
8
-
-
56649100785
-
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom
-
Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008;62:1261-1264.
-
(2008)
J. Antimicrob. Chemother.
, vol.62
, pp. 1261-1264
-
-
Woodford, N.1
Zhang, J.2
Warner, M.3
-
9
-
-
62749131175
-
Center for disease control and prevention (CDC): Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities
-
Available at:, Accessed March 20, 2009
-
Center for Disease Control and Prevention (CDC): guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5810a4.htm. Accessed March 20, 2009.
-
(2009)
MMWR Morb Mortal Wkly Rep.
, vol.58
, pp. 256-260
-
-
-
10
-
-
54949148412
-
National healthcare safety network team; Participating national healthcare safety network facilities. NHSN annual update: Antimicrobial- resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006-2007
-
Hidron AI, Edwards JR, Patel J, et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996.
-
(2008)
Infect. Control Hosp. Epidemiol.
, vol.29
, pp. 996
-
-
Hidron, A.I.1
Edwards, J.R.2
Patel, J.3
-
11
-
-
33750332075
-
CHINET 2005 surveillance of bacterial resistance in China
-
Wang F. CHINET 2005 surveillance of bacterial resistance in China. Chin J Infect Chemother 2006;6:289-295.
-
(2006)
Chin. J. Infect. Chemother.
, vol.6
, pp. 289-295
-
-
Wang, F.1
-
12
-
-
34548243954
-
CHINET 2005 surveillance of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae
-
Ye S, Yang Q, Yu Y. CHINET 2005 surveillance of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae. Chin J Infect Chemother 2007;7:283-286.
-
(2007)
Chin. J. Infect. Chemother.
, vol.7
, pp. 283-286
-
-
Ye, S.1
Yang, Q.2
Yu, Y.3
-
13
-
-
35448951860
-
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: A matched case control study
-
Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007;60:1124-1130.
-
(2007)
J. Antimicrob. Chemother.
, vol.60
, pp. 1124-1130
-
-
Falagas, M.E.1
Rafailidis, P.I.2
Kofteridis, D.3
-
14
-
-
18944362003
-
Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
-
Kwak YG, Choi SH, Choo EJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005;11:165-169.
-
(2005)
Microb. Drug Resist
, vol.11
, pp. 165-169
-
-
Kwak, Y.G.1
Choi, S.H.2
Choo, E.J.3
-
15
-
-
40549126250
-
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
-
Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-1033.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 1028-1033
-
-
Schwaber, M.J.1
Klarfeld-Lidji, S.2
Navon-Venezia, S.3
-
16
-
-
22144436291
-
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium
-
Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-1435.
-
(2005)
Arch. Intern. Med.
, vol.165
, pp. 1430-1435
-
-
Bratu, S.1
Landman, D.2
Haag, R.3
-
17
-
-
43949107942
-
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities
-
Urban C, Bradford PA, Tuckman M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities. Clin Infect Dis 2008;46: e127-e130.
-
(2008)
Clin. Infect. Dis.
, vol.46
-
-
Urban, C.1
Bradford, P.A.2
Tuckman, M.3
-
18
-
-
74549172183
-
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A prospective evaluation
-
Michalopoulos A, Virtzili S, Rafailidis P, et al. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect 2010;16:184-186.
-
(2010)
Clin. Microbiol. Infect.
, vol.16
, pp. 184-186
-
-
Michalopoulos, A.1
Virtzili, S.2
Rafailidis, P.3
-
19
-
-
0346100720
-
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study
-
Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004;48:224-248.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 224-248
-
-
Lee, S.O.1
Kim, N.J.2
Choi, S.H.3
-
20
-
-
11244284795
-
Risk factors for imipenem-resistant Pseudomonas aeruginosa: A comparative analysis of two case-control studies in hospitalized patients
-
Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect 2005;59:96-101.
-
(2005)
J. Hosp. Infect.
, vol.59
, pp. 96-101
-
-
Zavascki, A.P.1
Cruz, R.P.2
Goldani, L.Z.3
-
21
-
-
0035084032
-
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
-
Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-1161.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 1151-1161
-
-
Yigit, H.1
Queenan, A.M.2
Anderson, G.J.3
-
22
-
-
9644265318
-
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A betalactamase, KPC-3, in a New York medical center
-
Woodford N, Tierno PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A betalactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 2004;48:4793-4799.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 4793-4799
-
-
Woodford, N.1
Tierno Jr., P.M.2
Young, K.3
-
23
-
-
34247178075
-
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing betalactamase
-
Villegas MV, Lolans K, Correa A, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing betalactamase. Antimicrob Agents Chemother 2007;51:1553-1555.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 1553-1555
-
-
Villegas, M.V.1
Lolans, K.2
Correa, A.3
-
24
-
-
33748698691
-
Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
-
Navon-Venezia S, Chmelnitsky I, Leavitt A, et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006;50:3098-3101.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 3098-3101
-
-
Navon-Venezia, S.1
Chmelnitsky, I.2
Leavitt, A.3
-
25
-
-
41549114683
-
Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae
-
Cai JC, Zhou HW, Chen GX, et al. Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae. Zhonghua Yi Xue Za Zhi 2008;88:135-138.
-
(2008)
Zhonghua Yi Xue Za Zhi
, vol.88
, pp. 135-138
-
-
Cai, J.C.1
Zhou, H.W.2
Chen, G.X.3
-
26
-
-
40549135623
-
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression
-
Zhang R, Yang L, Cai JC, et al. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 2008;57:332-337.
-
(2008)
J. Med. Microbiol.
, vol.57
, pp. 332-337
-
-
Zhang, R.1
Yang, L.2
Cai, J.C.3
-
27
-
-
70349312522
-
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
-
Landman D, Bratu S, Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009;58:1303-1308.
-
(2009)
J. Med. Microbiol.
, vol.58
, pp. 1303-1308
-
-
Landman, D.1
Bratu, S.2
Quale, J.3
-
28
-
-
0344004830
-
Identification and characterization of a new porin gene of Klebsiella pneumoniae: Its role in beta-lactam antibiotic resistance
-
Doménech-Sánchez A, Hernández-Allés S, Martínez-Martínez L, et al. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol 1999;181:2726-2732.
-
(1999)
J. Bacteriol.
, vol.181
, pp. 2726-2732
-
-
Doménech-Sánchez, A.1
Hernández-Allés, S.2
Martínez-Martínez, L.3
-
29
-
-
23044475952
-
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycinresistant Enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice
-
Pultz NJ, Stiefel U, Donskey CJ. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycinresistant Enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 2005;49:3513-3516.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 3513-3516
-
-
Pultz, N.J.1
Stiefel, U.2
Donskey, C.J.3
|